Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination: an autopsy case.
about
Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells.Identification of glypican-3-derived long peptides activating both CD8(+) and CD4(+) T cells; prolonged overall survival in cancer patients with Th cell responsePhase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients.Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican‑3‑derived peptideHepatocellular carcinoma from an immunologic perspectiveHepatocellular Carcinoma With Tumor Thrombus Occupying the Right Atrium and Portal Vein: A Case Report and Literature Review.Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma.Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model.Trial Watch: Peptide vaccines in cancer therapy.Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma.Cancer Immunotherapy Targeted Glypican-3 or Neoantigens.Improvement of Peptide-Based Tumor Immunotherapy Using pH-Sensitive Fusogenic Polymer-Modified Liposomes.Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy.
P2860
Q35201631-7E38ABB1-6DF4-441D-9634-87636663D3B4Q36597336-8BA36A3F-6E30-449C-811C-DA835C4CBE34Q37012707-E64F4F40-D173-4448-93F7-0172D8E85AD1Q37313380-B707936D-774D-4B61-9F42-DB227BD82A89Q37402242-12E1BDD2-04E4-4C63-BF20-29F56FBDC51CQ38575075-68C5F4B3-F565-4331-B17A-0783BDA34480Q39358916-983DE526-3773-4197-8A3A-FD10546E6F06Q39378285-A2960CB2-4457-455B-9A4B-C13D6D1E6A80Q41683191-3C8431E4-DB35-44FE-B068-667F55557040Q42734544-17BA2B4A-580B-4173-A4E1-FCCC03E95ED5Q47140396-4AD5CF19-CDCD-4BBE-A30A-53EA08BF5762Q47760070-EE20EE62-ACDD-46EA-B193-6ADCD3131603Q51151392-5EE947C3-2A7D-4C55-ADF0-EC9BCE6E7058Q55715408-07583A5C-ED0C-481E-9EDA-8DB94F186BD8
P2860
Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination: an autopsy case.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Remarkable tumor lysis in a he ...... vaccination: an autopsy case.
@en
Remarkable tumor lysis in a he ...... vaccination: an autopsy case.
@nl
type
label
Remarkable tumor lysis in a he ...... vaccination: an autopsy case.
@en
Remarkable tumor lysis in a he ...... vaccination: an autopsy case.
@nl
prefLabel
Remarkable tumor lysis in a he ...... vaccination: an autopsy case.
@en
Remarkable tumor lysis in a he ...... vaccination: an autopsy case.
@nl
P2093
P2860
P356
P1476
Remarkable tumor lysis in a he ...... vaccination: an autopsy case.
@en
P2093
Chisako Yamauchi
Daisuke Nobuoka
Itaru Endo
Satoshi Fujii
Shoichi Mizuno
Shuichi Mitsunaga
Tetsuya Nakatsura
Toshiaki Yoshikawa
P2860
P304
P356
10.4161/HV.24179
P577
2013-03-06T00:00:00Z